Literature DB >> 31057682

Perspective in Nuclear Theranostics Using Exosome for the Brain.

Do Won Hwang1,2.   

Abstract

Owing to its highly biocompatible property as naturally produced nanoscale particle and drug carrying ability, exosome has attracted much interest in the biomedical area. Versatile functions of exosome in biological system play an important role in elucidating mysterious and unknown biological processes and pathological disease progression. For usage of exosome as brain disease therapeutics, even though the ability of exosomes crossing blood brain barrier (BBB) is not well clearly proven, the small size and their own characteristics possessing cell-derived molecular contents may provide great and beneficial tools for brain delivery and brain-associated disease therapy. A variety of trials related to bioapplications using stem cell-derived exosome in regenerative therapy or autologous exosome shuttling inhibitor targeting brain disease-associated protein marker enhance possibility of exosome toward clinical application. The radionuclide PET or SPECT imaging of radiolabeled exosome will be clearly able to provide accurate clues for analyzing their whole body distribution, targeting efficacy, and the degree of non-specific tissue uptake. In this perspective, the practical information on thranostics of exosome for brain delivery and therapy is offered and radionuclide-based exosome applicability will be dealt with.

Entities:  

Keywords:  Exosome; In vivo targeted therapy; Radionuclide imaging; Regenerative therapy; Theranostics

Year:  2019        PMID: 31057682      PMCID: PMC6473017          DOI: 10.1007/s13139-018-00567-6

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  42 in total

1.  Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice.

Authors:  Masaki Morishita; Yuki Takahashi; Makiya Nishikawa; Kohei Sano; Kana Kato; Takuma Yamashita; Takafumi Imai; Hideo Saji; Yoshinobu Takakura
Journal:  J Pharm Sci       Date:  2014-11-12       Impact factor: 3.534

Review 2.  Exosomes as nucleic acid nanocarriers.

Authors:  Jasper G van den Boorn; Juliane Dassler; Christoph Coch; Martin Schlee; Gunther Hartmann
Journal:  Adv Drug Deliv Rev       Date:  2012-06-28       Impact factor: 15.470

3.  Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Authors:  Matthew J Haney; Natalia L Klyachko; Yuling Zhao; Richa Gupta; Evgeniya G Plotnikova; Zhijian He; Tejash Patel; Aleksandr Piroyan; Marina Sokolsky; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

4.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

Authors:  Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

5.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.

Authors:  Lydia Alvarez-Erviti; Yiqi Seow; Haifang Yin; Corinne Betts; Samira Lakhal; Matthew J A Wood
Journal:  Nat Biotechnol       Date:  2011-03-20       Impact factor: 54.908

6.  Exosomes from dental pulp stem cells rescue human dopaminergic neurons from 6-hydroxy-dopamine-induced apoptosis.

Authors:  Akvilė Jarmalavičiūtė; Virginijus Tunaitis; Ugnė Pivoraitė; Algirdas Venalis; Augustas Pivoriūnas
Journal:  Cytotherapy       Date:  2015-05-13       Impact factor: 5.414

7.  Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.

Authors:  Shin-ichiro Ohno; Masakatsu Takanashi; Katsuko Sudo; Shinobu Ueda; Akio Ishikawa; Nagahisa Matsuyama; Koji Fujita; Takayuki Mizutani; Tadaaki Ohgi; Takahiro Ochiya; Noriko Gotoh; Masahiko Kuroda
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

Review 8.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

9.  Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury.

Authors:  Fatih Arslan; Ruenn Chai Lai; Mirjam B Smeets; Lars Akeroyd; Andre Choo; Eissa N E Aguor; Leo Timmers; Harold V van Rijen; Pieter A Doevendans; Gerard Pasterkamp; Sai Kiang Lim; Dominique P de Kleijn
Journal:  Stem Cell Res       Date:  2013-01-14       Impact factor: 2.020

10.  Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma.

Authors:  Huilin Shao; Jaehoon Chung; Kyungheon Lee; Leonora Balaj; Changwook Min; Bob S Carter; Fred H Hochberg; Xandra O Breakefield; Hakho Lee; Ralph Weissleder
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

View more
  1 in total

Review 1.  Radiolabelling of Extracellular Vesicles for PET and SPECT imaging.

Authors:  Azalea A Khan; Rafael T M de Rosales
Journal:  Nanotheranostics       Date:  2021-02-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.